Evidence map›Paper›PMID 39149394›Full record

ArticlebioRxiv : the preprint server for biology2024

Novel Insights into Post-Myocardial Infarction Cardiac Remodeling through Algorithmic Detection of Cell-Type Composition Shifts.

Brian Gural, Logan Kirkland, Abbey Hockett, Peyton Sandroni, Jiandong Zhang, Manuel Rosa-Garrido, Samantha K Swift, Douglas Chapski, Michael A Flinn, Caitlin C O'Meara and 4 more

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors.

Brian GuralDepartment of Genetics and Computational Medicine Program, UNC School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.ORCID 0000-0001-9741-6982
Logan KirklandMcAllister Heart Institute, UNC School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
Abbey HockettDepartment of Genetics and Computational Medicine Program, UNC School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
Peyton SandroniDepartment of Pharmacology, UNC School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.ORCID 0000-0002-8663-7963
Jiandong ZhangMcAllister Heart Institute, UNC School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
Manuel Rosa-GarridoDepartment of Biomedical Engineering, The University of Alabama at Birmingham, Birmingham, AL 35294, USA.ORCID 0000-0002-2169-3972
Samantha K SwiftDepartment of Cell Biology, Neurobiology, and Anatomy, Medical College of Wisconsin, Milwaukee, WI, 53226, USA.ORCID 0000-0002-5618-7578
Douglas ChapskiDepartments of Anesthesiology & Perioperative Medicine, Medicine/Cardiology, and Physiology, David Geffen School of Medicine; Molecular Biology Institute; University of California, Los Angeles, Los Angeles, CA 90095, USA.
Michael A FlinnDepartment of Physiology, Medical College of Wisconsin, Milwaukee, WI, 53226, USA.ORCID 0000-0002-8200-1693
Caitlin C O'MearaDepartment of Physiology, Medical College of Wisconsin, Milwaukee, WI, 53226, USA.
Thomas M VondriskaDepartments of Anesthesiology & Perioperative Medicine, Medicine/Cardiology, and Physiology, David Geffen School of Medicine; Molecular Biology Institute; University of California, Los Angeles, Los Angeles, CA 90095, USA.ORCID 0009-0000-5238-1245
Michaela PattersonDepartment of Cell Biology, Neurobiology, and Anatomy, Medical College of Wisconsin, Milwaukee, WI, 53226, USA.ORCID 0000-0002-3805-4181
Brian C JensenMcAllister Heart Institute, UNC School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
Christoph D RauDepartment of Genetics and Computational Medicine Program, UNC School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.ORCID 0000-0002-0782-207X

Funding

Pre-doctoral Training Program in Integrative Vascular BiologyT32HL069768 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Christopher P. Mack · 2002 to 2026
$9.7M
Dynamics of Cardiac Nuclei in Heart DiseaseR01HL105699 · NHLBI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI VONDRISKA, THOMAS M. · 2011 to 2025
$5.0M
Metabolic mechanisms of cardioprotection through alpha-1A adrenergic receptor activationR01HL140067 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Brian C Jensen · 2018 to 2026
$4.2M
Genetic interactions and multifactorial genetics mediate myocardial regenerationR01HL155085 · NHLBI · MEDICAL COLLEGE OF WISCONSIN · PI PATTERSON, MICHAELA · 2021 to 2025
$2.5M
Regulation of gene transcription and alternative splicing by a long non-coding RNAR01HL159086 · NHLBI · UNIVERSITY OF SOUTH FLORIDA · PI SONG, KUNHUA, VONDRISKA, THOMAS M. · 2022 to 2025
$2.1M
Elucidating the Role of Multinuclearity in Healthy and Diseased Mammalian CardiomyocytesR01HL162636 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Christoph Daniel Rau · 2023 to 2026
$1.9M
Discovery of Novel Epigenetic Regulators of Heart Failure in a Panel of MiceR00HL138301 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI RAU, CHRISTOPH DANIEL · 2020 to 2022
$747k
NHLBI NIH HHS R00 HL138301NHLBI NIH HHS R01 HL105699NHLBI NIH HHS R01 HL140067NHLBI NIH HHS R01 HL155085NHLBI NIH HHS R01 HL159086NHLBI NIH HHS R01 HL162636NHLBI NIH HHS T32 HL069768
6 · The paper itself

Abstract

Background: Recent advances in single cell sequencing have led to an increased focus on the role of cell-type composition in phenotypic presentation and disease progression. Cell-type composition research in the heart is challenging due to large, frequently multinucleated cardiomyocytes that preclude most single cell approaches from obtaining accurate measurements of cell composition. Our Methods: We have implemented an algorithmic approach that uses snRNAseq datasets as a reference to accurately calculate cell type compositions from bulk RNAseq datasets through robust data cleaning, gene selection, and multi-sample cross-subject and cross-cell-type deconvolution. We applied our approach to cardiomyocyte-specific α1A adrenergic receptor (CM-α1A-AR) knockout mice. 8-12 week-old mice (either WT or CM-α1A-KO) were subjected to permanent left coronary artery (LCA) ligation or sham surgery (n=4 per group). Transcriptomes from the infarct border zones were collected 3 days later and analyzed using our algorithm to determine cell-type abundances, corrected differential expression calculations using DESeq2, and validated these findings using RNAscope. Results: Uncorrected DEGs for the CM-α1A-KO X LCA interaction term featured many cell-type specific genes such as Conclusions: Our algorithm identifies and corrects for cell-type abundance in bulk RNAseq datasets opening new avenues for research on novel genes and pathways as well as an improved understanding of the role of cardiac cell types in cardiovascular disease.

Identifiers

PMID39149394
PMCPMC11326268

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.